Keene & Associates Inc. Acquires 2,585 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Keene & Associates Inc. boosted its stake in shares of Avanos Medical, Inc. (NYSE:AVNS) by 16.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,635 shares of the company’s stock after purchasing an additional 2,585 shares during the quarter. Keene & Associates Inc.’s holdings in Avanos Medical were worth $371,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the stock. EntryPoint Capital LLC raised its position in shares of Avanos Medical by 97.6% during the first quarter. EntryPoint Capital LLC now owns 5,601 shares of the company’s stock valued at $112,000 after buying an additional 2,766 shares during the last quarter. Janney Montgomery Scott LLC raised its holdings in Avanos Medical by 19.1% in the 1st quarter. Janney Montgomery Scott LLC now owns 13,010 shares of the company’s stock valued at $259,000 after acquiring an additional 2,082 shares in the last quarter. Natixis Advisors L.P. bought a new stake in shares of Avanos Medical in the 4th quarter worth approximately $317,000. Quest Partners LLC acquired a new stake in shares of Avanos Medical during the 4th quarter worth approximately $327,000. Finally, Pitcairn Co. raised its stake in shares of Avanos Medical by 11.2% in the first quarter. Pitcairn Co. now owns 15,940 shares of the company’s stock valued at $317,000 after purchasing an additional 1,606 shares in the last quarter. 95.17% of the stock is owned by institutional investors.

Avanos Medical Stock Up 2.0 %

Shares of AVNS stock opened at $24.00 on Monday. Avanos Medical, Inc. has a one year low of $17.24 and a one year high of $24.77. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.28 and a quick ratio of 1.49. The stock has a fifty day moving average price of $22.90 and a 200 day moving average price of $20.67. The stock has a market cap of $1.10 billion, a P/E ratio of -18.05 and a beta of 0.91.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.05. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The company had revenue of $171.70 million during the quarter, compared to the consensus estimate of $170.67 million. During the same period last year, the firm earned $0.24 EPS. The firm’s revenue for the quarter was up 1.4% compared to the same quarter last year. Analysts predict that Avanos Medical, Inc. will post 1.39 earnings per share for the current year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.